Evaluation of microemulsion and liposomes as carriers for oral delivery of transforming growth factor alpha in rats

References

• Angary AA, Bayomi MA, Khidr SH, Al-Meshal MA, Al-Dardiri M. Characterization, stability and in vivo targeting of liposomal formulations containing cyclosporine. Int J Pharm 1995; 114: 114–221
   Google Scholar
• Asada H, Douen T, Waki M, Adachi S, Fujita T, Yamamoto A, Muranishi S. Absorption characteristics of chemically modified-insulin derivates with various fatty acids in the small and large intestine. J Pharm Sci 1995; 84: 682–7
   PubMed Web of Science ®Google Scholar
• Blandizzi C, Geherardi G, Marveggio C, Lazeri G, Natale G, Carignani D, Colucci R, Del Taca M. Suramin enhances ethanol-induced injury to gastric mucosa in rats. Dig Dis Sci 1997; 42: 1233–41
   PubMed Web of Science ®Google Scholar
• Constantinides PP, Scalart JP, Lancaster C, Marcello J, Marks G, Ellens H, Smith PL. Formulation and intestinal absorption enhancement evaluation of water-in-oil microemulsions incorporating medium-chain glycerides. Pharm Res 1994; 11: 1385–90
   PubMed Web of Science ®Google Scholar
• Constantinides PP, Scalart JP. Formulation and physical characterization of water-in-oil microemulsions containing long-versus medium-chain glycerides. Int J Pharm 1997; 158: 57–68
   Web of Science ®Google Scholar
• Chalasani KB, Russell-Jones GJ, Jain A, Diwan P, Jain SK. Effective oral delivery of insulin in animal models using vitamin B12-coated dextran nanoparticles. J Control Rel 2007; 122: 141–50
   PubMed Web of Science ®Google Scholar
• Çelebi N, Türkyılmaz A, Gönül B, Özoğul C. Effects of epidermal growth factor microemulsion formulation on healing of stress-induced gastric ulcers in rats. J Control Rel 2002; 83: 197–210
   PubMed Web of Science ®Google Scholar
• Çilek A, Çelebi N, Tırnaksız F. Lecithin-based microemulsion of peptide for oral administration: Reparation, characterization and physical stability of formulation. Drug Deliv 2006; 13: 19–24
   PubMed Web of Science ®Google Scholar
• Çilek A, Çelebi N, Tırnaksız F, Tay A. A lecithin-based microemulsion of rh-insulin with aprotinin for oral administration: Investigation of hypoglycemic effects in non-diabetic and STZ-induced diabetic rats. Int J Pharm 2005; 298: 176–85
   PubMed Web of Science ®Google Scholar
• Graf A, Rades T, Hook SM. Oral insulin delivery using nanoparticles based on microemulsions with different structure-types: Optimisation and in vivo evaluation. Eur J Pharm Sci 2009; 37: 53–61
   PubMed Web of Science ®Google Scholar
• Iwanaga K, Ono S, Narioka K, Morimoto K, Kakemi M, Yamashita S, Nango M, Oku N. Oral delivery of insulin by using surface coating liposomes: Improvement of stability of insulin in GI tract. Int J Pharm 1997; 157: 73–80
   Web of Science ®Google Scholar
• Iwanaga K, Ono S, Narioka K, Kakemi M, Morimoto K, Yamashita S, Namba Y, Oku N. Application of surface-coated liposomes for oral delivery of peptide: Effect of coating the liposome's surface on the GI transit of insulin. J Pharm Sci 1999; 88: 248–52
   PubMed Web of Science ®Google Scholar
• Jorgensen KD, Diamant B. Inhibitory effect of aprotinin on gastric acid secretion. Scand J Gastroenterol 1984; 19: 999–1006
   PubMed Web of Science ®Google Scholar
• Kim SJ, Choi HK, Suh SP. Pharmacokinetic and pharmacodynamic evaluation of cyclosporine, an O/W-emulsion and microsphere formulations in rabbits. Eur J Pharm Sci 2002; 15: 497–502
   PubMed Web of Science ®Google Scholar
• Kim B, Peppas NA. In vitro release behavior and stability of insulin in complexation hydrogels as oral drug delivery carriers. Int J Pharm 2003; 266: 9–37
   Google Scholar
• Kisel MA, Kulik LN, Tsybovsky IS, Vlasov AP, Vorob’yov MS, Kholodava EA, Zabarovskaya ZV. Liposomes with phosphatidylethanol as a carrier for oral delivery of insulin: Studies in the rat. Int J Pharm 2001; 216: 105–14
   PubMed Web of Science ®Google Scholar
• Kompella UB, Lee VHL. Delivery systems for penetration enhancement of peptide and protein drugs: Design considerations. Adv Drug Deliv Rev 2001; 46: 211–45
   PubMed Web of Science ®Google Scholar
• Konturek PC, Bielanski W, Bobrzynski A, Hahn EG, Konturek SJ. Gastric mucosal expression and luminal release of growth factors in gastric carcinoma and duodenal ulcer patients before and after eradication of Helicobacter pylori. J Physiol Pharmacol 1997c; 48: 375–82
   PubMed Web of Science ®Google Scholar
• Konturek SJ, Brzozowski T, Majka J, Dembinski A, Slomiany A, Slomiany BL. Transforming growth factor alpha and epidermal growth factor in protection and healing of gastric mucosal injury. Scand J Gastroenterol 1992; 27: 649–55
   PubMed Web of Science ®Google Scholar
• Konturek PC, Ernst H, Konturek SJ, Bobrzynski AJ, Faller G, Klingler C, Hahn EG. Mucosal expression and luminal release of epidermal and transforming growth factor in patients with duodenal ulcer before and after eradication of Helicobacter pylori. Gut 1997b; 40: 463–9
   PubMed Web of Science ®Google Scholar
• Konturek JW, Hengst K, Konturek SJ, Domschke W. Epidermal growth factor in gastric ulcer healing by nocloprast, a stable prostaglandin E2 derivative. Scand J Gastroenterol 1997a; 32: 980–4
   PubMed Web of Science ®Google Scholar
• Konturek PC, Konturek SJ, Brzozwski T, Emst H. Epidermal growth factor and transforming growth factor-α; role in protection and healing of gastric mucosal lesions. J Gastroenterol 1995; 7: 933–8
   Web of Science ®Google Scholar
• Kristis GA. Viscosity study on oil-in-water microemulsion. Int J Pharm 1990; 61: 213–18
   Web of Science ®Google Scholar
• Lawrence MJ, Rees GD. Microemulsion-based media as novel drug delivery systems. Adv Drug Del Rev 2000; 45: 89–121
   PubMed Web of Science ®Google Scholar
• Li H, Song JH, Park JS, Han K. Polyethylene glycol-coated liposomes for oral delivery of recombinant human epidermal growth factor. Int J Pharm 2003; 258: 11–19
   PubMed Web of Science ®Google Scholar
• Louw JA, Modlin IM, Tang L, Young GO, Lucke W, Marks IN. Changes in mucosal levels of transforming growth factor-α from the oxyntic region and ulcer site during duodenal ulcer healing with ranitidine or sucralfate. J In Med Res 1998; 26: 82–6
   Google Scholar
• Ritschel WA. Microemulsions for improved peptide absorption from the gastrointestinal tract. Meth Find Exp Clin Pharmacol 1991; 13: 205–20
   PubMed Web of Science ®Google Scholar
• Romano M, Meise KS, Suozzo R, Sessa G, Persico M, Coffey R. Regional distribution of transforming growth factor-alpha and epidermal growth factor in normal and portal hypertensive gastric mucosa in humans. Dig Dis Sci 1995; 40: 263–7
   PubMed Web of Science ®Google Scholar
• Russo F, Messa C, Amati L, Carodonna L, Leoci C, Di Matteo G, Jirillo E, Dileo A. The influence of Helicobacter pylori eradication on the gastric mucosal content of epidermal growth factor, transforming growth factor-α and their common receptor. Scand J Gastroenterol 1998; 33: 271–5
   PubMed Web of Science ®Google Scholar
• Scheiman JM, Meise KS, Greenson JE, Coffey RJ. Transforming growth factor-alpha (TGF-α) levels in human proximal gastrointestinal epithelium: Effect of mucosal injury and acid inhibition. Dig Dis Sci 1997; 42: 333–41
   PubMed Web of Science ®Google Scholar
• Schultz GS, White M, Mitchell R, Brown G, Lynch J, Twardzik DR, Todaro GJ. Epithelial wound healing enhanced by transforming growth factor-α and vaccine growth factor. Sciences 1987; 235: 350–2
   PubMed Web of Science ®Google Scholar
• Scott-Moncrieff JC, Shao Z, Mitra AK. Enhancement of intestinal insulin absorption by bile salt fatty acid mixed micelles in dogs. J Pharm Sci 1994; 83: 1465–9
   PubMed Web of Science ®Google Scholar
• Silva-Cunha A, Chéron M, Grossiord JL, Puisieux F, Seiller M. W/O/W multiple emulsions of insulin containing a protease inhibitor and an absorption enhancer: Biological activity after oral administration to normal and diabetic rats. Int J Pharm 1998; 169: 33–44
   Web of Science ®Google Scholar
• Türkyılmaz A, Çelebi N, Gönül B, Alkan-Önyüksel H. Physical characterization and stability of a microemulsion for potential oral administration of a peptide. Biomedical science and technology, A Hıncal, S Kaş. Plenum Press, New York 1998; 65–72
   Google Scholar
• Wang W. Oral protein drug delivery. J Drug Target 1996; 4: 195–232
   PubMed Web of Science ®Google Scholar
• Yamamoto A, Taniguchi T, Rikyuu K, Tsuji T, Fujita T, Murakami M, Muranishi S. Effects of various protease inhibitors on the intestinal absorption and degradation of insulin in rats. Pharm Res 1994; 11: 1496–500
   PubMed Web of Science ®Google Scholar
• Yetkin G, Çelebi N, Özer Ç, Gönül B, Özoğul C. The healing effect of TGF-α on gastric ulcer induced by acetylsalicylic acid in rats. Int J Pharm 2004; 277: 163–72
   PubMed Web of Science ®Google Scholar
• Yin CH, Hong TL. Phospholipid components and preparation of liposomes containing protein drugs. Proceed Int Symp Control Rel Bioact Mater 1998; 25: 437–8
   Google Scholar
• Ziv E, Lior O, Kidron M. Absorption of protein via the intestinal wall. Biochem Pharm 1987; 36: 1035–9
   PubMed Web of Science ®Google Scholar